Clinical trial

Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed

NCT03537833

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-05-02

PhaseN/A

Study timeline

Study start (actual)2018-05-02Date precision: day

Registry last updated2022-02-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapyunresolved

Interventions

Sponsors & collaborators

CHU de Reimslead sponsor

Mapped research locations

ReimsFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03537833 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.